Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · NeoGenomics Laboratories (NEO)

NeoGenomics: Director Elizabeth Floegel resigns from board, effective immediately

Neutral Impact 2 of 5 leadership Written later

NeoGenomics director Elizabeth Floegel gave notice on August 5, 2025 that she is resigning from the Board of Directors, effective immediately. The company said her decision did not stem from any disagreement with it on operations, policies or practices.

Key points

  • Director Elizabeth Floegel resigned from the Board of Directors, effective immediately
  • Resignation notice was provided to the company on August 5, 2025
  • Company states no disagreement on operations, policies or practices led to the resignation
  • Filing dated August 8, 2025, signed by EVP, General Counsel and Corporate Secretary Alicia C. Olivo

The filing

CompanyNeoGenomics Laboratories (NEO)
Form8-K, current report
Filed with the SECAug 8, 2025, 4:03 PM ET
Accession number0001077183-25-000162

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:56 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 08, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.